Journal article · Vestibular← The news desk

✦ The Dispatch

Effectiveness and clinical predictors of rimegepant for acute vertigo in vestibular migraine: A real-world cohort study

A dispatch from PubMed — filed

In view of limited evidence-based acute treatments for spontaneous vertigo in vestibular migraine, this real-world cohort study assessed the effectiveness of rimegepant for acute vestibular migraine-related vertigo and factors associated with treatment response.MethodsClinical data were retrospectively collected from 86 patients with documented vestibular migraine treated with rimegepant 75 mg orally disintegrating...

Clinical Takeaway

Audiologists and vestibular specialists managing vestibular migraine patients should be aware that rimegepant shows real-world effectiveness for acute spontaneous vertigo episodes, and certain clinical predictors may help identify the best candidates — consider coordinating with neurology for prescribing.

Why It Matters

Vestibular migraine is among the most common causes of episodic vertigo and has limited acute treatment options; real-world evidence for rimegepant fills a meaningful evidence gap.

Key Points
  1. 01Rimegepant demonstrated effectiveness for acute spontaneous vertigo attacks in vestibular migraine patients.
  2. 02Clinical predictors of response were identified, potentially allowing patient selection in practice.
  3. 03This is a real-world cohort study, not an RCT, which limits causal inference.
  4. 04Published in Cephalalgia (DOI 10.1177/03331024261463533).
  5. 05Vestibular migraine is a leading but under-treated cause of episodic vertigo in adults.
Claims & Evidence

Rimegepant is effective for treating acute spontaneous vertigo in vestibular migraine patients.

studypartially supported

Specific clinical features can predict which vestibular migraine patients respond best to rimegepant.

studypartially supported
Research metadata
PMID
42377393
DOI
10.1177/03331024261463533.
Journal
Cephalalgia
Publication type
research_article
Evidence level
2b
Population
Patients with vestibular migraine experiencing acute spontaneous vertigo attacks
Intervention
Rimegepant for acute treatment of spontaneous vertigo in vestibular migraine

Primary outcomes

Effectiveness of rimegepant in reducing acute vertigo severity; Identification of clinical predictors of treatment response

Related stories